ID   NALM-6 TP53(-/-)
AC   CVCL_HE12
SY   TP53 (-/-) NALM-6
DR   cancercelllines; CVCL_HE12
DR   Horizon_Discovery; HD+115-049
DR   Wikidata; Q54907435
RX   PubMed=16405397;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; 11998; TP53.
CC   Sequence variation: Gene fusion; HGNC; 50800; DUX4 + HGNC; 5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 14
//
RX   PubMed=16405397; DOI=10.1089/dna.2006.25.19;
RA   Adachi N., So S., Iiizumi S., Nomura Y., Murai K., Yamakawa C.,
RA   Miyagawa K., Koyama H.;
RT   "The human pre-B cell line Nalm-6 is highly proficient in gene
RT   targeting by homologous recombination.";
RL   DNA Cell Biol. 25:19-24(2006).
//